Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.47 USD | +1.26% | +0.58% | +17.40% |
Jun. 11 | Myriad Genetics, GSK Partner to Expand Access to HRD Diagnostic Testing | MT |
May. 31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.40% | 2.01B | |
-9.00% | 11.67B | |
-4.32% | 8B | |
+6.37% | 5.72B | |
+30.76% | 5.5B | |
-14.91% | 3.84B | |
+11.39% | 2.66B | |
-61.44% | 2.66B | |
-9.76% | 2.3B | |
-6.79% | 1.78B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Transcript : Myriad Genetics, Inc., Q1 2024 Earnings Call, May 07, 2024